Huddersfield Pharmacy Specials has been contracted to provide quality assured GMP and GDP services for the ABC-12 Trial. HPS’ contracted activities include sourcing appropriate packaging, designing and providing Annex 13 compliant labelling, QP IMP certified release of Investigational Medicinal Products and temperature-controlled distribution to sites in the UK.

The ABC-12 Trial is exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine. Visit the ABC-12 trial website to learn more about the amazing research work.